Dr. Insco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana-Farber Cancer Institute
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-5055
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 2012 - 2015
Stanford University School of MedicineClass of 2012
Certifications & Licensure
MA State Medical License 2018 - 2025
NH State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Targeting RAF1 gene fusions with MEK inhibition in metastatic melanoma.Karam Khaddour, Rizwan Haq, Elizabeth I Buchbinder, David Liu, Michael P Manos
The Oncologist. 2024-11-06 - Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab.Anna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, Miklos C Fogarasi, Patrick A Ott
Journal for Immunotherapy of Cancer. 2024-08-28 - Specific oncogene activation of the cell of origin in mucosal melanoma.Swathy Babu, Jiajia Chen, Emily Robitschek, Chloé S Baron, Alicia McConnell
Biorxiv. 2024-04-26
Press Mentions
- Pandemic ProjectMarch 11th, 2021
Damon Runyon Cancer Research Foundation Awards $5.2 Million to Top Clinical InvestigatorsAugust 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
